Apyx Medical (NASDAQ:APYX) posted its quarterly earnings results on Wednesday, May 8th. The company reported ($0.14) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.18) by $0.04, Morningstar.com reports. The business had revenue of $5.82 million during the quarter. Apyx Medical had a negative return on equity of 12.25% and a net margin of 224.06%.
APYX stock opened at $6.03 on Friday. Apyx Medical has a twelve month low of $3.55 and a twelve month high of $8.89. The firm has a market capitalization of $210.38 million, a price-to-earnings ratio of -20.79 and a beta of 0.24.
A number of research firms have recently commented on APYX. Zacks Investment Research downgraded Apyx Medical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 18th. JMP Securities decreased their price target on Apyx Medical from $12.00 to $8.00 and set a “market outperform” rating on the stock in a report on Tuesday, April 2nd. TheStreet lowered Apyx Medical from a “c-” rating to a “d” rating in a report on Monday, May 20th. Piper Jaffray Companies decreased their price target on Apyx Medical to $7.00 and set an “overweight” rating on the stock in a report on Wednesday, May 8th. Finally, ValuEngine upgraded Apyx Medical from a “buy” rating to a “strong-buy” rating in a report on Monday, April 29th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $8.00.
About Apyx Medical
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.
Recommended Story: What Factors Can Affect Return on Equity?
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.